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Diacylglycerol (DAG) and phosphatidic acid (PA) are bioactive lipids synthesized when theT
cell receptor binds to a cognate peptide-MHC complex. DAG triggers signaling by recruiting
Ras guanyl-releasing protein 1, PKCθ, and other effectors, whereas PA binds to effector
molecules that include mechanistic target of rapamycin, Src homology region 2 domain-
containing phosphatase 1, and Raf1. While DAG-mediated pathways have been shown to
play vital roles in T cell development and function, the importance of PA-mediated signals
remains less clear.The diacylglycerol kinase (DGK) family of enzymes phosphorylates DAG
to produce PA, serving as a molecular switch that regulates the relative levels of these
critical second messengers. Two DGK isoforms, α and ζ, are predominantly expressed in T
lineage cells and play an important role in conventional αβ T cell development. In mature
T cells, the activity of these DGK isoforms aids in the maintenance of self-tolerance by
preventing T cell hyper-activation and promoting T cell anergy. In this review, we discuss
the roles of DAG-mediated pathways, PA-effectors, and DGKs in T cell development and
function. We also highlight recent work that has uncovered previously unappreciated roles
for DGK activity, for instance in invariant NKT cell development, anti-tumor and anti-viral
CD8 responses, and the directional secretion of soluble effectors.
Keywords: diacylglycerol kinase, phosphatidic acid, T cell development, T cell activation, T cell tolerance, T cell
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INTRODUCTION
Lipids are small hydrophobic molecules that perform a variety
of cellular functions. Though best known for their role in main-
taining cell structure and storing energy, lipids have gained in
importance over the past few decades as signaling mediators (1,
2). While lipids that participate in signaling are thought to be
much less abundant in the cell as compared to structural lipids,
their levels vary dynamically in response to external signals.
In this review, we discuss the signaling functions of two key
lipid second messengers, diacylglycerol (DAG) and phosphatidic
acid (PA), in the context of T cell development and function. DAGs
are esters of glycerol in which two of its hydroxyl groups are ester-
ified with long-chain fatty acids. One manner of PA generation in
cells is via phosphorylation of the free hydroxyl group in DAG by
a family of enzymes called diacylglycerol kinases (DGKs) (3, 4).
DGKs therefore act as molecular switches that simultaneously turn
off DAG-mediated signaling and turn on PA-mediated signals.
While all 10 mammalian DGK isoforms contain a kinase
domain and at least two cysteine-rich C1 domains, they can be
grouped into five types based on the homology of their other
structural features. α and ζ are the major isoforms expressed in
T cells (5). DGKα is a type I DGK and contains an N-terminal
recoverin homology domain and two Ca2+-binding EF hands.
DGKζ is a type IV DGK and contains a myristoylated alanine rich
C kinase substrate (MARCKS) motif, four ankyrin repeats and
a C-terminal PDZ-binding domain. DGKζ undergoes alternative
splicing, producing a 130 kDa ζ2 isoform that is highly expressed
in immature thymocytes and a 115 kDa ζ1 isoform that is predom-
inant in mature thymocytes and peripheral T cells (6). Functional
differences between the two splice variants remain unclear.
Here, we begin by discussing the various effector molecules
that transduce DAG-mediated signals and PA-mediated signals.
We then switch gears to review our current understanding of the
role of DGKs in T cell development and function with an emphasis
on recent advances that have revealed hitherto unknown functions
for these enzymes. The roles of DGK activity in other immune cell
lineages are also discussed briefly.
DAG-MEDIATED SIGNALING
Several enzymes contribute toward DAG production upon
receptor stimulation in immune cells (7) (Figure 1).
Phosphatidylinositol-dependent phospholipases hydrolyze mem-
brane phosphatidylinositol bisphosphate (PIP2) to DAG and
inositol triphosphate, and phosphatidylcholine (PC)-dependent
phospholipases hydrolyze PC to DAG and phosphoryl choline.
In addition, sphingomyelin synthase generates DAG and sphin-
gomyelin from PC and ceramide, while PA phosphatases such as
lipins dephosphorylate PA to DAG. On the other hand, DAG is
primarily removed by the activity of DGKs, which catalyze its
phosphorylation to PA. DAG can recruit a variety of downstream
effector molecules through their C1 domains, and thereby trigger
multiple signaling pathways.
The protein kinase C (PKC) family of serine/threonine kinases
consists of 10 isozymes that are activated by a number of distinct
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FIGURE 1 | Pathways involved in the generation and removal of DAG
and PA. Multiple pathways contribute to DAG generation in the cell,
including the hydrolysis of PIP2 by PI-dependent PLCs, hydrolysis of PC by
PC-dependent PLCs, dephosphorylation of PA by lipins, and sphingomyelin
synthesis by SMS. On the other hand, PA is generated by PLD-mediated
hydrolysis of PC and by DGK-mediated phosphorylation of DAG. As
bioactive lipids, both DAG and PA are able to bind to a number of effector
molecules, as listed.
mechanisms (8, 9). Upon engagement of the TCR, production of
DAG by activated PLCγ1 recruits PKCθ to the plasma membrane
in T cells. Co-stimulation via CD28 also plays an important role in
the recruitment and spatial segregation of PKCθ at the immuno-
logical synapse (10, 11). Activation of PKCθ is indispensable for
TCR-mediated NF-κB activation in mature T cells (12, 13). A role
for PKCθ has also been identified in an array of key processes (14)
including invariant NKT (iNKT) cell development and activation
(15, 16), T cell survival (17), IL-2 production (18), TH2 responses
(19, 20), and TH17 responses (21). Thus, by recruiting PKCθ, DAG
regulates multiple aspects of T cell function.
Another important protein that is brought to the plasma mem-
brane by DAG upon TCR stimulation is Ras guanyl-releasing
protein 1 (RasGRP1) (22). RasGRP1 is a member of the Ras-
GRP family of factors that help activate Ras by exchanging bound
GDP for GTP (23), and is selectively expressed in T cells and a few
other cell types (24). RasGRP1 plays an essential role in thymocyte
development (25), and is particularly required for the selection of
thymocytes that express weakly selecting TCRs (26). RasGRP1 is
not critical for the development of γδ T cells, but is important
for their proliferation and IL-17 production (27). Other studies
have shown that RasGRP1 may play a role in promoting antigen-
induced CD8 cell expansion by lowering the threshold of T cell
activation (28). RasGRP1 is therefore a key effector downstream
of DAG that plays a multitude of critical roles in T cell development
and function.
Members of the protein kinase D (PKD) family have been iden-
tified more recently as DAG effectors (29). A unique characteristic
of PKDs is that they are targets of both DAG and DAG-activated
PKCs (30). PKDs are thought to be activated by a multi-step mech-
anism. Upon cell stimulation, inactive PKD translocates from the
cytosol to the plasma membrane in response to membrane DAG
production, where it is then activated by novel PKCs that are also
recruited to the membrane by DAG. During T cell development,
PKD has been shown to exert different effects on VDJ recombi-
nation at the TCRβ locus and on CD4 and CD8 expression, based
on its localization at the cytosol or plasma membrane (31). Subse-
quent work has revealed that regulation of thymocyte development
by membrane-localized PKD, but not cytosol-localized PKD, is
dependent on the GTPase RhoA (32). Bringing PKD to the plasma
membrane therefore represents another important mechanism by
which DAG regulates T cell development.
Munc13 proteins are mammalian homologs of the C. elegans
Unc13 that is localized to pre-synaptic active zones of neurons
and important for neurotransmitter secretion (33). Munc13-1,
Munc13-2, and Munc13-3 isoforms bind to DAG with high affin-
ity, and translocate to the plasma membrane in response to recep-
tor stimulation. In the immune system, the Munc13-4 isoform
which lacks a C1 domain (34, 35) has been shown to be important
for granule maturation and exocytosis in NK cells and cytotoxic
T lymphocytes (CTLs) (36, 37), and for phagosomal maturation
and killing of intracellular bacteria in neutrophils (38, 39). Further
studies are required to investigate parallel roles for DAG-binding
Munc13 isoforms in NK cells, CTLs, neutrophils, and other types
of immune cells. Over-expressing human Munc13 in opossum
renal epithelial cell lines enhanced their susceptibility to apoptosis
after DAG treatment, suggesting that Munc13 proteins may trans-
duce apoptosis-inducing signals downstream of DAG in some cell
types (40). The role of Munc13 proteins in T cell development and
function remain poorly understood.
Chimaerins, a family of proteins that possess Rac-specific
GTPase Activating Protein (GAP) activity, contain C1 domains
that bear about 40 percent homology to those of PKCs (41, 42).
Chimaerin isoforms α2 and β2 are expressed at different levels
in T cells and have been shown to participate in TCR signaling
(43). Results from the study suggest that these chimaerin isoforms
translocate to the immunological synapse upon T cell activation,
but in a manner that is independent of canonical DAG-binding by
the C1 domains. Catalytic activity of these chimaerins was found
to play an important role in inhibiting TCR-mediated NFAT acti-
vation. Other studies have delineated a role for β2 chimaerin in
mediating DAG-dependent changes in T cell adhesion and chemo-
taxis (44). In this study, expression of GFP-tagged β2 chimaerin
revealed that active Rac and C1-dependent PMA binding could
co-operate to induce sustained localization of β2 chimaerin to the
plasma membrane in Jurkat T cells. Overexpression of GFP-β2
chimaerin was associated with decreased CXCL12-induced static
adhesion but enhanced CXCL12-induced migration. Chimaerin
proteins therefore represent an important class of DAG effectors
in T cells, but further work is required to dissect aspects of their
function that are dependent on and independent of DAG-binding.
PA-MEDIATED SIGNALING
Diacylglycerol kinases and enzymes of the phospholipase D
(PLDs) family act as key mediators of PA production in immune
cells by phosphorylating DAG and hydrolyzing PC, respectively
(7, 45) (Figure 1). On the other hand, enzymes such as lipins that
possess PA phosphatase activity play a critical role in turning off
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PA-mediated signaling by removing PA (46). Cellular levels of PA
have been shown to change dynamically in response to environ-
mental stimuli, and a wealth of data has revealed a diverse array of
functions for this bioactive lipid (47).
Phosphatidic acid performs its signaling functions primar-
ily by associating with a growing number of effector mole-
cules that include kinases such as mammalian/mechanistic target
of rapamycin (mTOR) and phosphatidylinositol-4-phosphate 5-
kinase (PIP5K), and phosphatases such as Src homology region
2 domain-containing phosphatase 1 (SHP1) (48). In mammalian
HEK293 cells, treatment with exogenous PA was found to promote
the phosphorylation of S6K1 and 4E-BP1, which are substrates
of mTOR complex 1 (49). This phosphorylation was abolished
by rapamycin, a bacterial macrolide that inhibits mTOR activ-
ity. Results from this study showed that mitogenic stimulation
of HEK293 cells led to cellular PA accumulation within 5 min.
Small unilamellar vesicles containing PA could also directly bind
to the FKBP12-rapamycin binding (FRB) domain on mTOR in a
manner that competed with FKBP12-rapamycin. Together, these
results suggest a role for PA as a critical mediator that connects
mitogenic stimuli to mTOR activation in mammalian cells (50).
More recent work has revealed that PA may activate mTOR by
a distinctive two-step mechanism that involves the displacement
of the endogenous mTOR-inhibitor FKBP38 and allosteric acti-
vation of the kinase (51). On the other hand, studies with Rat2
fibroblasts suggest that PA may indirectly activate mTOR complex
1 via the MEK-ERK pathway (52). In this study, two structurally
distinct MEK inhibitors were found to inhibit PA-mediated acti-
vation of mTOR complex 1. Other studies with human renal cell
adenocarcinoma cell lines have shown that suppression of cellular
PA production by treatment with a PLD inhibitor may inhibit the
association of mTOR with both Raptor and Rictor, suggesting that
PLD-derived PA may act as a key stabilizer of mTOR complexes 1
and 2 (53).
Diacylglycerol kinase-derived PA has also been shown to mod-
ulate mTOR complex 1 activity in HEK293 cell lines (54). Overex-
pression of DGKζ, but not DGKα, led to increased mTOR complex
1-dependent phosphorylation of S6K1 both in the presence and
absence of serum, suggesting that DGKζ-derived PA may acti-
vate mTOR complex 1. DGKζ-induced S6K1 phosphorylation was
dose-dependent, as cells expressing higher levels of DGKζ showed
more intense S6K1 phosphorylation. DGKζ-mediated increase in
S6K1 phosphorylation was abolished when a mutant form of
mTOR (that lacked the capacity to bind PA) was co-expressed, sug-
gesting that DGKζ-generated PA enhances S6K1 phosphorylation
by directly binding to mTOR.
While it is tempting to extend these observations to suggest that
PA may directly bind and activate mTOR in immune cells, only
a few studies have rigorously examined the relationship between
PA and mTOR in these cell types. RAW264.7 macrophage cell
lines showed enhanced secretion of pro-inflammatory cytokines
such as IL-6, TNF-α, and IL-1β in response to PA stimulation
(55). This was specifically abrogated by rapamycin, suggesting
that PA-induced production of pro-inflammatory cytokines in
macrophages may occur through the mTOR complex 1 pathway.
Treatment of mice with PA also led to an increase in serum lev-
els of these cytokines, suggesting that PA may promote systemic
inflammatory responses in a manner that is dependent on mTOR
complex 1 activation.
As we discuss later in this review, a bevy of studies provide clear
genetic evidence of critical roles for DGKα and DGKζ in multiple
aspects of T cell maturation and function. However, much work
remains to be done in understanding the role of DGK-derived
and PLD-derived PA in activating mTOR complex 1 during T cell
development and function.
Another key signaling pathway that is activated by PA is the
Ras/MEK/ERK signaling cascade (56). The first line of evidence
for PA-mediated modulation of MAP kinase signaling came from
a study which showed that a C-terminal domain of Raf1 could
bind to PA in a canine kidney cell line (57). Subsequent work
showed that growth factor-mediated activation of PLD and the
concomitant production of PA were directly linked to the acti-
vation of the Raf1-MAP kinase pathway (58). Based on findings
that insulin-dependent PLD activation was critically dependent on
ADP ribosylation factor (ARF) activation, the researchers used an
ARF inhibitor (brefeldin A) to block PLD activation (59). Block-
ing PLD activity and PA production with brefeldin A blocked
insulin-induced activation of the MAPK pathway in Rat-1 fibrob-
lasts. Results from the study also showed that PA did not directly
activate Raf1, but instead enhanced its recruitment to the plasma
membrane to allow for its activation by Ras. Mutations in Raf1
that disrupted Raf1-PA interaction prevented plasma membrane
recruitment of Raf1 in response to insulin stimulation (60).
Kinase suppressor of Ras 1 (KSR1) is a scaffolding protein that
interacts with several components of the Raf-MEK-ERK cascade
to co-ordinate the formation of localized multi-protein complexes
that enable efficient signal transduction (61). More recent work
has shown that KSR1 contains a sequence homologous to Raf1’s
PA-binding domain that allows it to directly bind PA and be
recruited to the plasma membrane in response to insulin stim-
ulation in fibroblasts (62). The recruitment of KSR1 by PA was
also found to be essential for its scaffolding function, as mutations
in its PA-binding motif impaired insulin-induced MEK and ERK
phosphorylation. Studies have shown that PA also recruits Sos,
an activator of Ras, to the plasma membrane through its plex-
trin homology domain (63). PLD2-derived PA was found to play
essential role in EGF-induced Ras activation, as mutations of Sos
that impaired PA-binding prevented its membrane recruitment
and subsequent activation of Ras.
Studies with Jurkat T cells suggest that PLD2 may act upstream
of RasGRP1 upon TCR crosslinking and co-stimulation via the
integrin lymphocyte function-associated antigen 1 (LFA1) (64). In
this case, production of PA by PLD2 and subsequent dephospho-
rylation of PA to DAG by PA phosphatase were shown to be critical
for plasma membrane Ras activation. Others have demonstrated
a role for PLD-derived PA in ERK1/2 activation downstream of
Galectin-8 engagement in Jurkat T cells (65). Galectins are a fam-
ily of widely expressed carbohydrate-recognizing proteins, and
Gal-8 has previously been shown to bind certain integrins on the
T cell surface to provide co-stimulatory and proliferative signals
(66). In this study, Gal-8 induced PA accumulation in Jurkat T
cells within 15 min in a manner that was inhibited by treatment
with a PLD inhibitor (1-butanol). Such PLD-inhibition also abro-
gated ERK1/2 phosphorylation, suggesting that PLD-derived PA
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may play an essential role in ERK activation downstream of Gal-8
stimulation in Jurkat T cells. However, this result must be inter-
preted with caution, as PLD-derived PA may also activate ERK in
an indirect manner involving the lipin-mediated conversion of PA
to DAG.
Type I PIP5K enzymes catalyze the production of PIP2 from
phosphatidylinositol-4-phosphate (PIP). During T cell activation,
PIP2 is involved in modulating T cell rigidity but is primarily
hydrolyzed to produce key second messengers DAG and inositol
triphosphate (IP3) (51). A number of studies have established that
PA can bind to and activate PIP5K (67). Modulation of PIP5K
activity by PA was originally shown using PIP5K purified from
bovine brain membranes, where PA was shown to enhance enzy-
matic activity by up to 20-fold (68). Subsequent studies demon-
strated that type I PIP5Ks (which phosphorylate PIP to PIP2),
but not type II PIP5Ks (which phosphorylate phosphatidylinos-
itol 5 phosphate to PIP2), are specifically regulated by PA (69).
More recent work has suggested that PA may regulate the affin-
ity of murine PIP5K-1β for its substrate PIP (70). In this study,
PA was shown to bind specifically to the C-terminal region of
PIP5K-1β and kinetic analysis revealed that the addition of PA
increased the affinity of PIP-binding to the enzyme’s active site
by nearly 70-fold. Other studies have elegantly demonstrated a
role for DGKζ-derived PA in stimulating PIP5K-1α activity to
increase local PIP2 levels and promote actin polymerization in
cell lines (71). Expression of DGKζ enhanced PIP5K-1α activity
in thrombin-stimulated HEK293 cells, and DGKζ and PIP5K-1α
were found to co-localize and co-immunoprecipitate with each
other. DGKζ and PIP5K-1α were also found to co-localize with
actin at lamellipodial protrusions in epithelial cells. While there is
evidence to suggest that the activity of PIP5K-1α and γ isoforms
may be critical for normal human NK cell cytotoxicity (72, 73),
the role of PLD-derived and DGK-derived PA in regulating PIP5K
activity in immune cells remains quite poorly understood.
Protein phosphatase 1 (PP1) is a eukaryotic serine/threonine
phosphatase that regulates the function of a variety of proteins in
the cell. The PP1 catalytic subunit is able to interact with more
than 50 different regulatory subunits in a mutually exclusive man-
ner and this allows the enzyme to target different substrates in
diverse subcellular locations depending on its binding partner
(74). Initial studies identified that PA acted as a highly specific
tight-binding inhibitor of the γ isoform of human PP1 in vitro
(75). Further studies used a deletion mutagenesis approach to
reveal that residues 286–296 of PP1γwere necessary and sufficient
for PA-binding (76). Results from one study suggest that PP1 activ-
ity may play a role in suppressing T cell function in a rat model
of alcohol intoxication and burn injury (77). While this suggests
that PA-mediated inhibition of PP1 function may facilitate T cell
activation, further experiments are required to better understand
the role of PLD-derived and DGK-derived PA in suppressing PP1
activity in T cells.
Src homology region 2 domain-containing phosphatase 1 is
a tyrosine phosphatase that plays a critical role in T cell function
(78).“Moth-eaten”mice carry a spontaneous frame-shift mutation
in the SHP1 gene and lack detectable SHP1 protein (79). Studies
with these mice revealed a role for SHP1 in negatively regulat-
ing positive and negative thymocyte selection (80), while the use
of conditional SHP1 knockout mice showed that SHP1 limits the
number of short-lived effector CD8 cells produced in response to
viral infection (81). Early studies showed that PA could increase the
phosphatase activity of SHP1 toward the EGF receptor when the
two proteins were transiently co-expressed in 293 cells (82). Sub-
sequently, PA was shown to directly bind to recombinant SHP1,
and two distinct PA-binding sites (a high affinity site on the C-
terminal end and a low affinity site on the N-terminal end) were
identified on SHP1 (83). Future studies are required to determine
if PA modulates SHP1 activity in immune cells and if PA may serve
as an effective therapeutic agent to modulate immune responses.
ROLE OF DGK ACTIVITY IN THYMOCYTE DEVELOPMENT
Bone marrow-derived early progenitor cells must go through an
elaborate process of development in the thymus to become mature
T cells (84, 85). Thymocytes at different stages of maturation are
readily distinguished by a combination of CD4 and CD8 co-
receptors expressed on their cell surface, proceeding from the
earliest stage with neither CD4 nor CD8 (double negative/DN)
through an intermediate stage expressing both CD4 and CD8
(double positive/DP) to a mature stage marked by the expres-
sion of either CD4 or CD8 (CD4 single positive/CD4SP or CD8
single positive/CD8SP) (86, 87). While progenitor cells enter the
thymus at the cortico-medullary junction, a number of sequential
chemokine/chemokine-receptor interactions help guide a devel-
oping thymocyte through the thymic cortex and medulla, facilitat-
ing its progressive relocation to appropriate micro-environments
within the thymus (88, 89).
With the expression of RAG proteins, DN cells undergo VDJ
recombination at the TCRβ locus, expressing a pre-TCR on the
cell membrane. DN cells with a productive TCRβ rearrange-
ment pass through the β-selection developmental checkpoint,
undergoing multiple rounds of proliferation and upregulating
expression of CD4 and CD8 to become DP cells. DP cells sub-
sequently rearrange V and J genes at the TCRα locus, expressing a
unique TCR on the cell surface. Subsequently, cells bearing TCRs
that recognize self-peptide-MHC complexes on thymic epithelial
cells receive survival signals during the so-called positive selec-
tion process, while others that fail to recognize these complexes
die of “neglect” (90, 91). On the other hand, DP cells with TCRs
that recognize self-peptide-MHC complexes with high affinity are
eliminated by apoptosis-inducing signals during negative selec-
tion (92, 93). Together, positive and negative selection processes
ensure the generation of a T cell repertoire that is both functional
and self-tolerant (94, 95). DP cells that survive these selection
processes mature into CD4SP and CD8SP cells that eventually
migrate to secondary lymphoid organs as naïve CD4 and CD8 T
cells (96, 97).
A plethora of studies have implicated DAG-dependent signal-
ing pathways in β, positive and negative selection. For instance,
early studies showed that signaling via the pre-TCR activates
ERK1/2 (98), while more recent ones have demonstrated an essen-
tial role for RasGRP1 and ERK activation in efficient β-selection
(27, 99). Mice with a T cell-specific deficiency of PLCγ1 show
dramatically reduced numbers of mature CD4SP and CD8SP
thymocytes, and defects in both positive and negative selection
when crossed with HY TCR transgenic mice (100). Impairment
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of thymic selection in the absence of PLCγ1 suggests that its
product DAG may play an important role in the process. Lend-
ing further credence to this notion, RasGRP1-deficient mice show
impaired Ras-ERK signaling in thymocytes and defective thymic
selection with a 70–90% reduction of mature SP cells (25, 26).
Transgenic mice expressing a dominant negative form of Ras
present with defects in positive selection, but not negative selec-
tion, when crossed with HY TCR transgenic mice (101). Similar
observations were made with transgenic mice that expressed a cat-
alytically inactive form of MEK1 (K97A) under the control of the
thymocyte-specific Lck proximal promoter (102). ERK1 deficiency
results in a severe developmental block at the DP stage (103).
Conditional deletion of ERK2 using proximal Lck-Cre partially
blocked DN3 to DN4 progression, while deletion with CD4-Cre
led to defective positive selection. Mice with a combined defi-
ciency of ERK1 and ERK2 showed that ERK activity is required
for proliferation and differentiation associated with β-selection,
and for positive selection (104). The MAP kinase-interacting ser-
ine/threonine kinases (Mnks) 1 and 2 lie downstream of ERK1/2
and p38 (105, 106). Recent studies have shown that TCR trigger-
ing can activate Mnk1/2 via the Ras-ERK pathway in a manner
that is negatively regulated by DGK αζ activity (107). Although
Mnk1/2 phosphorylate EIF4E, which is thought to promote trans-
lation initiation, combined deficiency of Mnk1/2 did not lead to
obvious changes in thymocyte development. The mechanisms
by which ERK1/2 regulate thymocyte selection remain to be
clearly defined. Together, these studies suggest that the DAG-
RasGRP1-Ras-ERK pathway plays a critical role in thymocyte
development.
The role of the DAG-mediated PKCθ-IKK-NF-κB pathway in
T cell development has also been studied extensively. While initial
studies found no obvious developmental defects in PKCθ deficient
thymocytes, more recent ones have suggested that PKCθ may be
required for efficient positive selection (108, 109). T cell-specific
deletion of IKKγ or replacement of IKKβwith a dominant kinase-
dead form results in a reduction of mature CD8SP cells (110),
while transgenic models that allow for activation or inhibition
of NF-κB have revealed its role in the establishment of signaling
thresholds for positive and negative selection (111).
The importance of these DAG-mediated pathways suggests that
their tight regulation by DGK may be critical for normal thy-
mocyte development. Studies with mice that lack both DGKα
and DGKζ (DGKαζDKO) have confirmed this hypothesis (112).
DGKαζDKO thymocytes experience excessive DAG accumulation
and enhanced DAG-mediated signaling after TCR engagement.
This is associated with a severe developmental block at the DP stage
and a marked paucity of mature CD4SP and CD8SP cells. Defects
in positive, but not negative, selection were revealed using a HY
TCR transgenic system. Addition of exogenous PA to fetal thymic
organ cultures increased the frequency of SP cells in DGKαζDKO
thymi without obvious effects on control thymi, suggesting that
DGKα and DGKζ play a synergistic role in T cell development not
just by dampening DAG-mediated signals but also by promoting
PA-mediated signals. This DGK-induced switch from DAG-driven
to PA-driven signals may also play a critical role in preventing pro-
longed activation of the highly oncogenic Ras-ERK and NF-κB
pathways in developing thymocytes. Indeed, HY TCR transgenic
mice with decreased DGK activity showed significantly enhanced
thymic lymphomagenesis, suggesting an important role for DGK
activity in tumor suppression (112).
More recent work from our group has uncovered a novel role
for DGKs as negative regulators of mTOR activity in thymocytes
(113). Results from the study showed that low concentrations of
phorbol 12-myristate 13-acetate (PMA), a functional analog of
DAG, were able to induce phosphorylation of mTOR complex
1 substrates S6K1 and 4E-BP1 and mTOR complex 2 substrate
Akt (S473), suggesting that DAG-mediated signaling is sufficient
to induce activation of both mTOR complexes in thymocytes.
DGKαζDKO thymocytes showed enhanced phosphorylation of
S6K1,4E-BP1, and Akt (S473) upon TCR engagement as compared
to WT counterparts, suggesting that DGK activity inhibits TCR-
induced activation of mTORc1 and mTORc2. Further studies are
required to determine if dysregulated mTOR signaling might con-
tribute to the defects in T cell development and function observed
in DGKαζDKO mice.
Emerging evidence also suggests that tight regulation of DAG-
mediated signaling by DGK activity may be critical for the develop-
ment of iNKT cells. iNKT cells are a rare but distinct lineage of αβ
T cells that express a highly restricted TCR repertoire and recognize
glycolipids presented on CD1d. Sometimes called the“Swiss-Army
knife” of the immune system, iNKT cells bridge innate and adap-
tive immunity by performing an array of functions that include
killing of infected cells and secretion of cytokines and chemokines
(114). Despite their relative rarity, an important role for iNKT
cells has been demonstrated in immune responses to pathogens,
allergens, self-antigens, and cancer.
Previous work has revealed a critical role for signaling via the
PKCθ-IKK-NF-κB pathway in the ontogeny of iNKT cells (15,
115–117). More recent studies have identified that RasGRP1-Ras-
ERK signaling may also be indispensable for iNKT development.
In one study, the absence of RasGRP1 was associated with a
severe reduction of iNKT cell numbers in the thymus, spleen,
and liver (118). The generation of bone marrow chimeras showed
that the iNKT cell developmental defects were cell-intrinsic, and
the remaining RasGRP1-deficient iNKT cell population displayed
both a selective absence of CD4+ cells and defects in TCR-induced
proliferation. In another study, the expression of a dominant
negative form of Ras dramatically hindered iNKT development
(118, 119).
While lack of IKK-NF-κB and Ras-ERK signaling is detrimental
to iNKT cell development, recent findings indicate that hyperac-
tive signaling via these DAG-mediated pathways may also perturb
iNKT development (120). In this study, T lineage specific expres-
sion of a constitutively active form of Ras resulted in a late stage
block in iNKT cell maturation, and constitutively IKKβ activity
was associated with increased cell death at multiple developmental
stages. Since the maintenance of optimal levels of DAG-mediated
signaling appears to be essential for normal iNKT development,
we hypothesized that tight regulation of DAG-mediated signals
by DGK activity might be essential for this process. Results from
our studies showed that while iNKT cell numbers were unaltered
in mice lacking either DGKα or DGKζ, they were dramatically
diminished in DGKαζDKO counterparts, suggesting that these
DGK isoforms may play a redundant role in regulating iNKT cell
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development (120). Defective DGKαζDKO iNKT development
was associated with enhanced cell death and co-incident with
enhanced activation of the Ras-ERK and NF-κB pathways. Taken
together, these results suggest that DGKα and DGKζ work syner-
gistically to maintain an optimal level of DAG-mediated signaling
that is essential for normal iNKT development.
ROLE OF DGK ACTIVITY IN T CELL FUNCTION
DGKα AND DGKζ IN T CELL ACTIVATION
T cell activation is a dynamic cellular process that involves the
activation of multiple signaling cascades (Figure 2). The termi-
nation of such signaling, however, is important to prevent unre-
strained immune responses and the development of autoimmu-
nity. Research over the last decade has delineated a role for DGKα
and DGKζ isoforms as molecular brakes that terminate DAG-
mediated signals after TCR engagement. Early studies demon-
strated that DGKζ is expressed in multiple lymphoid organs,
with high levels in the T cell compartment (6). Overexpression
of DGKζ in Jurkat T cells indicated that it substantially hin-
dered TCR-induced Ras-ERK activation and upregulation of the
activation marker CD69. DAG-binding and kinase domains, but
not the ankyrin repeats, of DGKζ were found to be required
for these inhibitory effects. Analysis of germline DGKζ knock-
out mice revealed no dramatic differences in T cell development
or homeostasis (121). However, DGKζ-deficient T cells showed
enhanced Ras-ERK activation and diminished PA production
upon TCR engagement. Complementing observations from the
Jurkat system, DGKζ-deficiency resulted in increased upregula-
tion of CD69 and CD25 (markers of T cell activation) upon
TCR engagement. Consistent with enhanced activation, DGKζKO
T cells were hyper-proliferative in response to both antigenic
stimulation and lymphopenia.
The role of DGKα in controlling T cell activation largely
parallels that of its ζ counterpart. Overexpression of DGKα in
Jurkat cells greatly impaired TCR-induced activation of a co-
transfected AP1 driven luciferase reporter construct without obvi-
ous effects on calcium influx (122). While DGKαKO mice did not
present with obvious changes in T cell development or homeosta-
sis, enhanced Ras-ERK activation and hyper-proliferation were
observed upon TCR engagement in DGKαKO T cells. Taken
together, these results suggest that DGKα and DGKζ act in a
non-redundant manner to restrain DAG-mediated signaling and
prevent T cell hyper-activation upon TCR engagement. Further
studies are required to better understand the unique mechanisms
by which these isoforms act.
DGKα AND DGKζ IN T CELL ANERGY
Mechanisms of central and peripheral tolerance play a critical role
in preventing the development of autoimmunity (123, 124). T
cell anergy is a form of peripheral tolerance whereby T cells that
FIGURE 2 | Signaling pathways triggered byTCR and CD28
engagement. When the TCR engages a cognate peptide-MHC complex in
the presence of appropriate co-stimulatory signals, this activates TCR
proximal tyrosine kinases (PTKs) and results in the recruitment of a number
of adaptor molecules. Eventually, the activation of PLCγ1 enables it to
hydrolyze membrane PIP2 to form second messengers IP3 and DAG. IP3
activates the calcineurin-NFAT pathway, while DAG activates the
Ras-ERK-AP1 and NF-κB pathways. DGKs dampen DAG-mediated signals by
converting DAG to PA. CD28 engagement plays an important role in the
activation of PKCθ and the PI3K-Akt-mTOR axis. Recent work (indicated by
thick arrows) has shown that TCR signaling can also directly activate mTOR
complexes via the Ras-ERK pathway, and that such activation is negatively
regulated by DGK activity. ERK can also activate Mnk1/2 kinases that
phosphorylate eIF4E to promote translation. PA is produced in T cells by the
action of both DGKs and PLDs (not shown in this figure). In other cell types,
PA has been shown to activate Raf1 and mTORc1. Please refer to the text
for more details about TCR-triggered signaling pathways and effector
molecules that bind to DAG or PA.
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recognize self-antigen in the absence of co-stimulatory signals are
rendered functionally inactive (125–128).
While anergic T cells express elevated levels of DGKα as com-
pared to naïve counterparts, levels of DGKζ increase or remain
unchanged depending upon the experimental system (122, 129,
130). Transduction of resting Coxsackievirus and adenovirus
receptor (CAR) transgenic TH1 cells with DGKα or DGKζ-
containing adenoviral constructs revealed that overexpression of
DGKα, but not DGKζ, was sufficient to cause an anergy-like state
(130). TH1 cells transduced with the DGKα construct showed
diminished ERK activation and IL-2 production in response to
stimulation with anti-CD3 and anti-CD28. Experiments with
RAG2-deficient 2C TCR transgenic cells also indicated that DGKα
overexpression resulted in impaired recruitment of RasGRP1 to
the plasma membrane. Brief treatment of anergic TH1 cells with
a pharmacological inhibitor of DGK activity before overnight re-
stimulation with anti-CD3 and anti-CD28 led to a dose-dependent
increase in IL-2 production, suggesting a causal function for high
DGK activity in T cell anergy. Similar results were obtained with
RAG2-deficient 2C TCR transgenic T cells that had been rendered
anergic in vivo.
Genetic evidence for the role of DGKα activity in T cell anergy
comes from an in vivo anergy induction model in which mice
were injected with the super-antigen staphylococcal enterotoxin B
(SEB) that renders Vβ8+ T cells anergic (122). When re-stimulated
with SEB ex vivo, in contrast to WT counterparts,Vβ8+ T cells from
DGKαKO mice retained the ability to produce IL-2 and proliferate.
These findings complement the data from the adenoviral-based
over-expression studies, and confirm that DGKα is essential for
anergy induction in vivo.
Further studies also indicate that DGKα and DGKζ may play
synergistic roles in anergy induction (122). When splenocytes from
WT, DGKαKO, and DGKζKO mice were depleted of CD8 cells and
stimulated in the presence of anti-CD3 and CTLA4-Ig (to block
co-stimulatory signals), DGKαKO, and DGKζKO T cells under-
went 2–3 rounds of proliferation in contrast to WT counterparts
that did not divide. Proliferation of DGKζKO T cells under similar
culture conditions was highly enhanced by the addition of a DGKα
inhibitor, and was comparable to that of WT cells stimulated with
anti-CD3 and anti-CD28. These results support the notion that α
and ζ DGK isoforms may act in a synergistic manner to induce T
cell anergy.
ROLE AND REGULATION OF DGKα AND DGKζ AT THE PLASMA
MEMBRANE
Early studies found that in T cell lines, DGKα translocated from
the cytosol to the plasma membrane in response to stimula-
tion via an ectopically expressed muscarinic type 1 receptor as
well as via the TCR (131). Examination of the redistribution of
GFP-tagged DGKα revealed rapid but transient translocation of
cytosolic DGKα to the plasma membrane after anti-CD3 and
anti-CD28 crosslinking. Tyrosine-kinase phosphorylation, along
with increases in intracellular calcium levels, was found to be
essential for receptor-induced membrane translocation of DGKα.
Pre-treatment of cells with the type I DGK inhibitor R59949
enhanced DGKα translocation to the plasma membrane at 2 min
but also prevented DGKα dissociation from the membrane even
after 60 min, suggesting that removal of DAG to produce PA may
play a critical role in enzyme release. Results from this study thus
showed that plasma membrane localization of DGKα is controlled
not just by receptor-derived signals, but also by its own enzymatic
activity.
More recent work has suggested that direct tyrosine phospho-
rylation of DGKα by the Src family kinase Lck may promote its
membrane association in T cells (132). Results from the study
showed that Lck phosphorylates DGKα at the Y335 residue in the
hinge region between its C1 domains and the kinase domain. TCR
triggering was found to induce rapid and transient phosphoryla-
tion of DGKα at Y335 in both Jurkat cells and primary human
T cells. Fractionation analysis of Jurkat cells revealed that Y335-
phosphorylation was detected only in the membrane-associated
(but not cytosolic) fraction. In addition, a Y335F mutant form of
DGKα failed to show plasma membrane localization in response
to anti-CD3/anti-CD28 stimulation, in contrast to its WT coun-
terpart. Immuno-precipitation experiments showed that Lck and
DGKα interacted with each other, but that the pool of DGKα
pulled down with Lck was not phosphorylated at Y335. The
authors hypothesize that Lck-mediated phosphorylation of DGKα
may induce the latter’s dissociation from Lck but play a role in
stabilizing DGKα at the membrane. Intriguingly, calcium flux
induced by ionomycin was able to increase Y335-phosphorylation
of DGKα, leading the authors to hypothesize that binding of Ca++
to DGKα’s EF hands might induce a conformation change that
increases Lck-mediated phosphorylation in the basal state.
Another study has since shown that c-Abl, a tyrosine-kinase
involved in regulating cell cycle and proliferation, directly phos-
phorylates DGKα at Y218 in NIH 3T3 cells (133). Phosphorylation
of this residue is thought to play an important role in serum-
induced export of DGKα from the nucleus to the cytosol, as a
Y218F mutant form was not exported from the nucleus in response
to serum addition.
A role for SAP (an adaptor molecule recruited by the SLAM
family of co-receptors) in inhibiting DGKα activity following
TCR/CD28 stimulation has also been identified recently (134).
Results from the study showed that DGKα (but not DGKζ) activity
was reduced in response to TCR/CD28 or TCR/SLAM stimulation
in Jurkat cells and human peripheral blood lymphocytes. However,
such inhibition was not observed in Jurkat cells upon shRNA-
mediated knockdown of SAP. SAP knockdown was also found
to impair the recruitment of DGKα to the plasma membrane
selectively upon TCR/SLAM stimulation,but not TCR/CD28 stim-
ulation, suggesting that the enzymatic activity and localization
of DGKα may be regulated by distinct mechanisms. Overexpres-
sion of SAP was sufficient to reduce DGKα activity in Jurkat cells,
providing further evidence of SAP’s role as a negative regulator.
Such a role for SAP is also corroborated by findings from previous
studies that SAP-deficient T cells showed reduced recruitment of
PKCθ to the plasma membrane and diminished ERK1/2 activation
upon TCR stimulation, leading to abnormal T cell differentiation
and function (19). Pharmacological inhibition of DGKα activ-
ity by R59949 partially restored PKCθ membrane recruitment,
ERK1/2 activation, and IL-2 production by SAP-deficient cells,
suggesting that unrestrained DGKα activity might contribute to
these signaling defects in the absence of SAP.
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Like its α counterpart, the ζ isoform of DGK also shows
dynamic changes in its subcellular localization in response to sig-
nals via the TCR. Early studies showed that GFP-tagged DGKζ
rapidly translocated from the cytosol to the plasma membrane
upon stimulation of an ectopically expressed muscarinic type 1
receptor, but not the TCR, in Jurkat T cells (135). Deletion of
the C-terminal domain (containing the PDZ-binding domain and
the ankyrin repeats), however, enabled DGKζ to translocate to
the plasma membrane following TCR stimulation, suggesting that
these domains may negatively regulate membrane translocation.
The results also revealed that intact cysteine-rich C1 domains
and PKCθ-mediated phosphorylation of the MARCKS domain
are essential for DGKζ membrane translocation, while enzymatic
activity is dispensable. Others have shown that DGKζ can translo-
cate to the nucleus in COS-7 cells, and that this translocation
is regulated by PKC-mediated phosphorylation of the MARCKS
motif (136). Future studies should investigate a role for DGKζ in
regulating nuclear DAG levels in immune cells.
When a T cell recognizes cognate peptide-MHC complexes and
co-stimulatory molecules on an antigen-presenting cell (APC),
this leads to the formation of a specialized junction at the T cell-
APC interface. This so-called “immunological synapse” typically
consists of a central cluster of T cell receptors surrounded by a ring
of adhesion molecules, and synapse formation is thought to sus-
tain robust signaling by facilitating the co-localization of kinases
and adaptor proteins while excluding phosphatases (137, 138).
Previous studies have shown that DGKζ can physically asso-
ciate with RasGRP1 in co-transfection experiments, but a similar
function for DGKα was not tested (139). A recent study directly
analyzed the recruitment of DGKα and DGKζ to the immuno-
logical synapse (140). Affinity purification of TCR complexes
from Jurkat cells activated by anti-CD3 and anti-CD28 crosslink-
ing suggested that both DGK isoforms were recruited rapidly to
the TCR complex. However, video-microscopic experiments with
GFP-tagged DGK proteins indicated that only DGKζ translocates
rapidly to the plasma membrane at the early stages of synapse
formation. These discrepant results need to be interpreted with
caution,as fusion with GFP could potentially alter a protein’s struc-
ture and disrupt its normal localization pattern. However, RNA
interference experiments from this study showed that PA produc-
tion at the TCR complex was substantially reduced by knock down
of DGKζ but not DGKα, strengthening the notion of functional
differences between the isoforms. The addition of PMA was found
to enhance DGKζ activity upon TCR stimulation, indicating that
DAG itself may regulate DGKζ activity. The use of a fluorescently
tagged DAG-sensor domain showed that both plasma membrane
localization and kinase activity of DGKζ were critical for DAG
consumption at the immune synapse. Together, these results indi-
cate a specific function for the DGKζ isoform in regulating DAG
levels at the immunological synapse. Further studies are required
to fully characterize the TCR-induced translocation of DGKα and
DGKζ in primary T cells.
DAG AND T CELL SECRETION
The directed release of soluble factors is an important mechanism
by which T cells kill target cells and communicate with other cell
types. Early studies have shown that the microtubule-organizing
center (MTOC) of a T cell reorients itself to a position just below
the immunological synapse within minutes of TCR stimulation.
Such polarization is though to aid in directional secretion by align-
ing the protein synthesis and secretion machinery of the T cell
with the immune synapse (141, 142). Inhibiting MTOC transloca-
tion after TCR stimulation resulted in reduced phosphorylation of
ZAP70 and LAT, disorganized immune synapse architecture and
impaired IL-2 secretion, suggesting that MTOC translocation may
also play a critical role in synapse formation and sustained TCR
signaling (143).
More recent studies using a photoactivation system in which
individual T helper cells can be activated by a pulse of ultraviolet
light, have revealed a critical role for localized DAG production in
MTOC polarization toward the synapse (144). MTOC polarization
was abrogated in the presence of a PLCγ1 inhibitor, but unaffected
in the presence of a Ca2+ chelator, suggesting that DAG may play
a critical role in the process. Treatment with PMA, but not iono-
mycin, disrupted MTOC polarization providing further evidence
that DAG, not Ca2+, links PLCγ1 activity to MTOC polarization.
Data from imaging experiments showed robust accumulation of
DAG-sensor proteins at the region of photoactivation, followed
by reorientation of MTOC to this region with an average delay of
13 s between the two events. Treatment with a DGK inhibitor pre-
vented sustained C1-GFP accumulation at the irradiated region
and thereby impaired MTOC polarization. Experiments with a
version of DAG that could be activated by ultraviolet light showed
that a localized increase in DAG concentration was sufficient to
drive transient polarization of the MTOC. Taken together, these
experiments indicate an important role for DAG and DGKs in
directional secretion. Treatment with PMA or a type II DGK
inhibitor impaired T cell-mediated killing of target cells, without
affecting degranulation. This suggests that localized DAG signal-
ing plays a critical role in CTL killing not by blocking granule
release but by directing the granules toward their appropriate tar-
get. Further studies using the photoactivation system have shown
that DAG recruits three distinct PKC isoforms, ε, η, and θ, to the
immune synapse to promote cytoskeletal polarization following
TCR stimulation (145).
A role for DGKα has also been established in the secretion of
lethal FasL-bearing exosomes during activation induced cell death
(AICD) (146). In this study, pre-treatment with a type I DGKα
inhibitor increased the secretion of FasL-bearing exosomes upon
TCR stimulation, and enhanced FasL-dependent AICD in J-HM1-
2.2 cell line, suggesting that DGK may act as a negative regulator
of exosome secretion. Based on the co-localization of DGKα with
the trans-Golgi network and its presence in secreted exosomes, the
authors proposed a model by which DAG may recruit PKD1 to the
trans-Golgi network to promote vesicle budding.
Building on these results, a more recent study has identified
a role for DGKα in the polarization of multi-vesicular bodies
(MVBs) involved in the secretion of FasL-bearing exosomes (147).
MVBs are late endosomes containing multiple exosomes/vesicles
within their lumen that are formed by inward budding of the lim-
iting membrane. In this study, inhibition of DGKα activity with
a type I inhibitor was found to increase the number of mature
MVBs, while overexpression of DGKα inhibited their formation,
indicating that DGKα may negatively regulate the formation of
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MVBs. However, siRNA-mediated inhibition of DGKα impaired
the polarization of MVBs and subsequent exosome release, sug-
gesting a positive role for DGKα in this process. Thus, DGKα
plays a complex role in the secretion of FasL-bearing exosomes,
impairing their formation but aiding their polarization toward
the immune synapse.
DGKα AND DGKζ IN CTL RESPONSES
CD8 responses or CTL responses are critical for host defense
against intracellular pathogens and tumors. CTL responses typ-
ically consist of three distinct phases – an expansion phase during
which antigen-specific CD8 cells proliferate rapidly and differen-
tiate into effector cells that kill infected target cells, a contrac-
tion phase during which 90–95 percent of these effector CD8
cells undergo apoptosis in response to diminishing antigen lev-
els, and a memory maintenance phase in which the remaining
5–10 percent of cells are retained as a small but stable pool of
fast-responding memory cells (148–150). Much effort over the
recent years has focused on how signaling mechanisms in CD8
cells can be manipulated to alter the amplitude and kinetics of the
CTL response. Preliminary experiments with lymphocytic chori-
omeningitis virus (LCMV) infection showed that mice deficient
in DGKζ mounted a more robust response to the pathogen than
WT counterparts (121). DGKζ-deficient mice showed a greater
increase of splenic CD8 cell numbers than WT mice at day 7, with
a bigger portion of CD62Llo CD44hi effector-memory (TEM) cells
and IFNγ-producing cells within the CD8 population. Viral titers
were 50–70 percent lower in DGKζ-deficient mice than WT mice,
arguing that DGKζ activity may negatively regulate CTL responses.
These results were confirmed and extended by a subsequent
study, which showed that DGK activity differentially regulates pri-
mary and memory responses to LCMV (151). In this study, both
DGKαKO and DGKζKO mice showed enhanced expansion and
increased cytokine production upon LCMV infection, but con-
tained fewer memory cells than WT counterparts after a 4-month
period. When equal numbers of memory cells from these mice
were transferred to new recipients and re-challenged with LCMV,
DGK-deficient memory cells expanded significantly less than WT
memory cells, indicating that DGK activity may somehow pro-
mote the expansion of memory cells. Other studies have revealed
that the temporal kinetics of mTORc1 activity may play a critical
role in effector versus memory differentiation of CD8 cells (152,
153). Results from these studies suggest that sustained mTORc1
activity may induce the expression of the T-box transcription fac-
tor T-bet that promotes effector differentiation. The identification
of DGKs as negative regulators of mTOR activity (113) suggests
the possibility that sustained mTORc1 activity in DGK-deficient
CD8 cells might favor effector differentiation and mitigate mem-
ory formation. While mTORc1 activity was indeed found to be
elevated in DGK-deficient CD8 cells (as measured by phospho-
rylation of the ribosomal protein S6) (151), further studies are
required to dissect the contribution of enhanced mTORc1 activ-
ity to the dysregulation of CD8 responses seen in DGKαKO and
DGKζKO mice.
DGKζ also acts as a negative regulator of anti-tumor CTL
responses in an EL4-Ova lymphoma model (154). In this model,
significantly smaller tumors were recovered from DGKζ-deficient
mice as compared to WT mice,3 weeks after implantation of tumor
cells. Evaluation of CD8 splenocytes revealed a higher propor-
tion of TEM cells and a higher proportion of Ova-specific CD8
cells in DGKζ-deficient mice than in WT mice. An increased
percentage of tumor-infiltrating CD8 cells was also found to be
proliferating in DGKζ-deficient mice as compared to WT coun-
terparts. Taken together, these results suggest that DGKζ activity
may play a critical role in restraining anti-tumor responses, closely
mirroring its functions during CTL responses to viral infection.
When naïve WT-OT1 and DGKζKO-OT1 cells were adoptively
transferred into congenically marked recipients that subsequently
received EL4-Ova lymphoma cells, recipients with DGKζKO-OT1
cells developed smaller tumors. DGKζKO-OT1 cells also contained
a bigger pool of CD44hi cells and IL-2 producing cells. Collec-
tively, these results argue for a CD8 cell-intrinsic role for DGKζ in
curtailing anti-tumor responses.
Investigation of tumor-infiltrating CD8 cells in human renal
cell carcinoma patients showed increased DGKα activity and
diminished signaling via MAPK pathways, as compared to CD8
cells that were present in non-tumor areas of the kidney (155).
Increased DGKα activity was associated with defects in granule
exocytosis and lytic function of these CD8 cells, and treatment
with a DGKα inhibitor was able to increase ERK phosphorylation.
Table 1 | Biological functions of DGKs inT cells and other immune
cells.
Functions regulated by DGK activity Reference
DAG metabolism at the T cell-APC
immunological synapse
Sanjuan et al. (131)
Topham and Prescott (139)
Santos et al. (135)
Merino et al. (132)
Baldanzi et al. (134)
Gharbi et al. (140)
Matsubara et al. (133)
Development of αβT cells Guo et al. (112)
Gorentla et al. (113)
Development of iNKT cells Shen et al. (120)
T cell activation and anergy Zhong et al. (6)
Zhong et al. (121)
Olenchock et al. (158)
Zha et al. (130)
CD8 T cell responses to pathogens and
tumors
Zhong et al. (121)
Riese et al. (154)
Prinz et al. (155)
Shin et al. (151)
MTOC polarization and directional secretion Alonso et al. (146)
Quann et al. (144)
Alonso et al. (147)
Mast cell degranulation and cytokine
production
Olenchock et al. (158)
Macrophage and DC cytokine production Liu et al. (159)
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Culturing with low-dose IL-2 reduced DGKα expression and
enhanced ERK activation and degranulation. IL-2 treatment also
increased the frequency of tumor-infiltrating cells that produced
perforin, granzyme B, or IFNγ. Taken together, these data indi-
cate that increased DGK activity and DAG metabolism dampen
the responsiveness of tumor-infiltrating CTLs in a reversible man-
ner. What factors in the tumor microenvironment drive increased
DGK activity in CD8 cells is an important question that remains
to be addressed.
ROLE OF DGK ACTIVITY IN OTHER IMMUNE CELLS
Apart from T cells, DAG and PA are critical signaling intermedi-
ates in several cell types including mast cells, dendritic cells (DCs),
and macrophages. It is therefore not surprising that tight reg-
ulation of DAG and PA levels by DGK activity is essential for
normal functioning of these cell types. Mast cells are abundant
at the host’s interface with the environment, such as the skin and
mucose (156). While best known for their role in the pathogenesis
of asthma, allergy, and anaphylaxis, mast cells also play a crit-
ical role in pathogen surveillance and defense against parasites
(157). In contrast to observations with T cells, mast cell function
in vivo was diminished in the absence of the DGKζ, impair-
ment of local anaphylactic responses (158). Bone marrow-derived
mast cells that lacked DGKζ showed impaired degranulation but
enhanced production of cytokines such as IL-6 when stimulated
ex vivo. Other studies have shown that both the ζ1 and ζ2 iso-
forms of DGKζ expressed in bone marrow-derived macrophages
and DCs, with ζ1 being predominant (159). Considered “pro-
fessional phagocytes,” macrophages, and DCs express a diverse
array of pattern recognition receptors (including toll-like recep-
tors or TLRs) that enable them to detect the presence of pathogens
and cell debris. Upon stimulation with Toxoplasma gondii – stable
tachyzoite antigen (STAg, which activates multiple TLRs), DGKζ-
deficient splenic DCs and bone marrow-derived macrophages
(BMMφ) produced less TNFα and IL-12 p40 than WT counter-
parts. Consistent with this impairment in cytokine production,
both resistance to endotoxin shock and susceptibility to T. gondii
infection were increased in DGKζ KO mice. While these findings
provide tantalizing evidence of a role for DGKζ in regulating innate
immune responses, further studies are required to gain a better
understanding of the underlying molecular mechanisms. In addi-
tion, the involvement of other DGK isoforms in the regulation of
innate immune responses remains to be investigated. The varied
biological functions of DGK activity in T cells and other immune
cells are summarized in Table 1.
SUMMARY
Over the past few years, a remarkable number of elegant studies
that have furthered our understanding of the roles of DAG-
mediated and PA-mediated signaling pathways, and their regu-
lation by enzymes of the DGK family, in T cell development and
function. A role for DGK activity has been identified in a variety of
critical processes including conventional αβ T cell and iNKT cell
development, T cell activation and anergy, directional secretion,
and suppression of CD8 responses against viruses and tumors.
While a multitude of interesting and fundamental questions in the
field have been addressed by these recent studies, it is important to
note that perhaps just as many others await answers. The roles of
DGK-derived PA and PLD-derived PA in T cell development and
function have proved challenging to dissect, as have differences
between DGK isoforms in terms of substrate specificity and sub-
cellular localization. Key elements such as transcription factors,
microRNAs, and post-translational modifications that control the
dynamic expression and function of DGKs during a T cell’s life-
time also remain relatively unexplored. Applying the scientific
method to answer these intriguing questions is likely to yield
a better understanding of how DAG and PA signals and DGK
activity regulate immune responses, enhancing our ability to mod-
ulate such responses to quell self-reactivity or generate protective
immunity.
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